Skip to main navigation Skip to search Skip to main content

Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer's disease

  • Thomas J. Montine
  • , Sarah E. Monsell
  • , Thomas G. Beach
  • , Eileen H. Bigio
  • , Yunqi Bu
  • , Nigel J. Cairns
  • , Matthew Frosch
  • , Jonathan Henriksen
  • , Julia Kofler
  • , Walter A. Kukull
  • , Edward B. Lee
  • , Peter T. Nelson
  • , Aimee M. Schantz
  • , Julie A. Schneider
  • , Joshua A. Sonnen
  • , John Q. Trojanowski
  • , Harry V. Vinters
  • , Xiao Hua Zhou
  • , Bradley T. Hyman

Research output: Contribution to journalArticlepeer-review

97 Scopus citations

Abstract

Introduction Neuropathologic assessment is the current "gold standard" for evaluating the Alzheimer's disease (AD), but there is no consensus on the methods used. Methods Fifteen unstained slides (8 brain regions) from each of the 14 cases were prepared and distributed to 10 different National Institute on Aging AD Centers for application of usual staining and evaluation following recently revised guidelines for AD neuropathologic change. Results Current practice used in the AD Centers Program achieved robustly excellent agreement for the severity score for AD neuropathologic change (average weighted κ =.88, 95% confidence interval: 0.77-0.95) and good-to-excellent agreement for the three supporting scores. Some improvement was observed with consensus evaluation but not with central staining of slides. Evaluation of glass slides and digitally prepared whole-slide images was comparable. Discussion AD neuropathologic evaluation as performed across AD Centers yields data that have high agreement with potential modifications for modest improvements.

Original languageEnglish
Pages (from-to)164-169
Number of pages6
JournalAlzheimer's and Dementia
Volume12
Issue number2
DOIs
StatePublished - Feb 1 2016

Bibliographical note

Publisher Copyright:
© 2016 The Alzheimer's Association.

Funding

This work was supported by the following grants from the National Institute on Aging , National Institutes of Health : the, National Alzheimer's Coordinating Center ( U01 AG016976 ), Alzheimer's Disease Centers ( P50 AG05133 , P50 AG05134 , P50 AG05136 , P50 AG05681 , P30 AG10161 , P30 AG10124 , P30 AG13854 , P50 AG16570 , P30 AG19610 , and P30 AG28383 ), and P01 AG03991 . We thank Dr Kathleen Montine for editorial assistance. This work was supported by the following grants from the National Institute on Aging, National Institutes of Health: the, National Alzheimer''s Coordinating Center (U01 AG016976), Alzheimer''s Disease Centers (P50 AG05133, P50 AG05134, P50 AG05136, P50 AG05681, P30 AG10161, P30 AG10124, P30 AG13854, P50 AG16570, P30 AG19610, and P30 AG28383), and P01 AG03991. We thank Dr Kathleen Montine for editorial assistance.

FundersFunder number
Alzheimer's Disease CentersP50 AG05133, P30 AG10124, P50 AG16570, P50 AG05134, P30 AG28383, P50 AG05136, P30 AG13854, P30 AG19610, P01 AG03991, P30 AG10161, P50 AG05681
National Alzheimer's Coordinating CenterU01 AG016976
National Institutes of Health (NIH)
National Institute on AgingP50AG005134, P01AG003991

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • Alzheimer's disease
    • Methods
    • Multisite
    • Neuropathology
    • Whole-slide imaging

    ASJC Scopus subject areas

    • Epidemiology
    • Health Policy
    • Developmental Neuroscience
    • Clinical Neurology
    • Geriatrics and Gerontology
    • Cellular and Molecular Neuroscience
    • Psychiatry and Mental health

    Fingerprint

    Dive into the research topics of 'Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer's disease'. Together they form a unique fingerprint.

    Cite this